Docetaxel and RF Hyperthermia for Lung Cancer
Author Information
Author(s): Jiang Zhu, Yan Wang, Ming Jiang, Yu Yang
Primary Institution: Cancer Center of West China (Hua Xi) Hospital, Si Chuan University
Hypothesis
To evaluate the feasibility and therapeutic effect of chemotherapy combined with regional radio frequency hyperthermia for pretreated locally advanced non-small cell lung cancer.
Conclusion
The combination of chemotherapy and regional hyperthermia was safe and showed promising tumor control and survival rates.
Supporting Evidence
- The overall response rate was 25.9%.
- The tumor control rate was 66.6%.
- Median progression free survival was 4 months.
- Median overall survival was 11 months.
Takeaway
Doctors combined a special heat treatment with chemotherapy to help patients with lung cancer, and it seemed to work pretty well.
Methodology
29 patients received up to 4 cycles of chemotherapy and 32 sessions of RF hyperthermia, with survival and toxicity evaluated.
Limitations
The study had a small sample size and was preliminary, requiring further research.
Participant Demographics
{"median_age":57,"gender_distribution":{"male":21,"female":8},"histological_subtype":{"squamous_carcinoma":11,"adenocarcinoma":18},"stage_distribution":{"IIIa":12,"IIIb":17}}
Statistical Information
Confidence Interval
{"PFS":"1.9–6.1 months","OS":"9.3–12.8 months"}
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website